What Clients Say

"Your skills would be well applied to any kind of writing project, from general reviews to the most scientific papers and grants." -- Daniel R. Salomon, M.D., The Scripps Research Institute
"After your editing, and using the cover letter you wrote to highlight the importance of the work, the manuscript was subsequently accepted in Vaccine without further revisions. This is the first time I have had a full-length manuscript accepted without revision. It was a pleasure working with you." -- Andrew Lees, Ph.D., Biosynexus Incorporated
"As a grant writer, Tom Hollon showed a particular ability to gather information through research and interviews, and to present a clear, logical and coherent case. He was able to work on a very tight deadline and was flexible in scheduling. The grant was funded for $2 million. We are looking forward to using his services again." -- Nora B. Doherty, BioCrossroads
"Wow! Tom, you have blown me away with all of the work you have done on this. Thank you, thank you, thank you! I am really excited by what you have put together here." -- Stewart Lyman, Ph.D., Lyman Biopharma Consulting
"I've re-read your Biodefenders article (actually, several times) and I wanted to tell you again how very excellent it is! You did such a fabulous job of explaining the current state of research and biodefense preparedness. It serves as a superb source of information. I'd love to have you write for Signals again (and again!)." -- Jennifer Van Brunt, Ph.D., Editor, Signals

Companies, Foundations, Societies, and Universities

  • AFG Biosolutions
  • Amara Medical
  • BioCrossroads
  • Biosynexus Incorporated
  • BIO Ventures for Global Health
  • Bridge Laboratories
  • Correlogic Systems
  • Dana Foundation
  • Discovery Logic
  • Federation of American Societies for Experimental Biology (FASEB)
  • Feinstein Kean Healthcare
  • Fina Biosolutions
  • Financial Communications, Inc.
  • GE Healthcare
  • Gene Logic
  • Gentra Systems
  • Gyrus ACMI
  • Health Legacy Partnership
  • Health Pathways
  • Hybridon
  • Hybrigenics, SA
  • IMC
  • INCAPS
  • Johns Hopkins University
  • Lentigen
  • Lyman BioPharma Consulting
  • MaxCyte
  • MedImmune
  • Molecular Design International
  • OriGene Technologies
  • Psychiatric Genomics
  • Recombinant Capital
  • Scripps Florida
  • Society for Women’s Health Research
  • Steinerman Biomedical Communications
  • Tacitus
  • Vanderbilt University

Publications

  • BioResearch Online
  • BrainWork
  • CancerPage
  • CHI Advances Reports
  • Clinical Researcher
  • Drug Discovery Online
  • Drug Topics
  • EarthWatch Journal
  • Gene Letter
  • GeneticHealth
  • Genome Technology
  • Journal of the National Cancer Institute
  • IAVI Report
  • The Lancet
  • Nature Biotechnology
  • Nature Medicine
  • New Choices
  • NIDA Notes
  • Pharmacy Practice News
  • Reuters Health Online
  • Science and Practice Perspectives
  • Science Next Wave
  • The Scientist
  • Signals
  • Technology Review
  • Weekly Briefings of the New England Journal of Medicine